HealthTech

Strive Health

Strive Health raises $550M Series D at $2.5B valuation

$550M
Total Raised
Series D
Latest Round
2018
Founded
1000+
Employees
Denver, CO
1 min read

Quick Facts

Valuation
$2.5B
Latest Round Size
$550M
Latest Round Date
September 2025

Strive Health: Series D Funding Round

Strive Health has successfully raised $550M in Series D funding, reaching a valuation of $2.5B.

Company Overview

Care provider for kidney disease patients with value-based model

Funding Details

The Series D round was led by General Atlantic, with participation from Fidelity.

Company Information

  • Headquarters: Denver, CO
  • Founded: 2018
  • Employees: 1000+
  • Category: HealthTech

Investment

Strive Health plans to use the funds to accelerate product development, expand its team, and scale operations globally.

About the Investors

  • General Atlantic: Verified investor in Series D
  • Fidelity: Verified investor in Series D

Key Investors

General Atlantic
Lead Investor
Verified investor in Series D
Fidelity
Investor
Verified investor in Series D

About the Author

Editorial Team
Editorial Team
Curated funding news from verified sources